Interferon, The Purdue Frederick Co. deal

IFSC reacquired from Purdue Pharma the U.S. and Canadian marketing rights to Alferon N Injection for $3.3 million. Last May, IFSC received an option from Purdue Pharma to reacquire the rights. The ev...